Plain-English translation of NCT07417904 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests a program called BRAVE, which is a brief, skills-based intervention designed to help young adults with early psychosis manage violence risk. BRAVE uses cognitive-behavioral therapy techniques—tools that help people recognize harmful thought patterns and develop safer coping strategies—and is delivered as part of regular early psychosis care. The study will look at whether the program is practical, acceptable to patients, and effective at reducing violence-related behaviors.
Young adults in the early stages of psychosis are at higher risk for violent behavior, but very few programs specifically target the factors that drive this risk in this population. This trial exists to test whether this new treatment can fill that gap and offer a practical option within existing mental health services.
You likely qualify if…
You likely don't qualify if…
You would start by receiving your regular early psychosis clinic care for a period of time. Then you would be randomly moved into the BRAVE program, where you would attend weekly skills-building sessions alongside your ongoing routine care. A trusted person in your life (like a family member or close friend) would also complete some study assessments to help the researchers understand how you're doing. Throughout the study, you would complete regular check-ins and assessments at different time points.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States